share_log

HC Wainwright & Co. Maintains Buy on Cidara Therapeutics, Maintains $6 Price Target

Benzinga ·  Apr 8 14:20

HC Wainwright & Co. analyst Ed Arce maintains Cidara Therapeutics (NASDAQ:CDTX) with a Buy and maintains $6 price target.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment